Investment case
Alkermes plc
ALKS · 4 developments mapped · last assessed 2026-09-21
Market Ontology has mapped 4 macro, policy, and market developments to Alkermes plc since 2026-08-12. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for ALKS yet, so no modelled value is shown. The ALKS valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run ALKS on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHD
Direct positive clinical trial results for a pipeline asset, reducing R&D risk and increasing future revenue potential.
· Moves probability of success for alks 7290, peak sales estimates for alks 7290, discount rate (reflecting reduced risk)
- Open question
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
Governance improvement, strategic oversight, potential for enhanced decision-making and risk management.
· Moves qualitative assessment of management and governance effectiveness, long term growth prospects (indirectly, through improved strategy)
What changed, by assumption
- 2026-09-21Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHD
- 2026-08-12Alkermes plc. Announces Refinancing of Tranche B Term Loans and Repricing of Tranche A Term Loans
- 2026-09-16Alkermes plc Appoints Anne C. Whitaker to Board of Directors
- 2026-09-16Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-07-08 | Net debt | Bearish | Liability-management transactions often reduce gross debt or push maturities out. | 0.70 |
| 2026-07-08 | Interest expense | Bearish | Tender/exchange extends maturity profile and typically lowers near-term interest expense. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-21 | Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHD | Bullish | 1-3m | 0.80 |
| 2026-09-16 | Alkermes plc Appoints Anne C. Whitaker to Board of Directors | Bullish | 3-12m | 0.20 |
| 2026-09-16 | Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors | watch | 3-12m | 0.10 |
| 2026-08-12 | Alkermes plc. Announces Refinancing of Tranche B Term Loans and Repricing of Tranche A Term Loans | Bullish | 1-3m | 0.70 |